4//SEC Filing
DEMANE MICHAEL F 4
Accession 0001610717-23-000107
CIK 0001444380other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:36 PM ET
Size
8.0 KB
Accession
0001610717-23-000107
Insider Transaction Report
Form 4
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
- Gift
Common Stock
2023-06-07−80,000→ 27,772 total
Holdings
- 131,225(indirect: See footnote)
Common Stock
- 18,266(indirect: See footnote)
Common Stock
- 122,541(indirect: See footnote)
Common Stock
- 164,344(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Includes 6,754 restricted stock units.
- [F2]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
- [F4]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
- [F5]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
- [F6]Reflects the transfer of 40,000 directly held shares to each of the SLAT Trust and the 2011 Trust on June 7, 2023.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001174533
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:36 PM ET
- Size
- 8.0 KB